bioRxiv Science⌕ Search

Biology subjects

Hoersch, S.

Publications and source records attributed to Hoersch, S..

5 recordsLinked to original sources

Single Cell Foundation Models Evaluation (scFME) for In-Silico Perturbation

Foundation models pre-trained on large single-cell RNA atlases offer a compelling alternative to in-vitro experimentation for understanding gene regulatory networks and conducting gene perturbation analyses, with significant implications for target identification. Numerous foundation models have been developed, building upon early efforts such as Geneformer and scGPT. Hyperparameter optimization also results in multiple variants which require comparative analysis. Current benchmarking approaches focus on feature-based assessments or intuitive biological and statistical tasks, which may not align with the models training objectives. A recent study proposed a systematic benchmarking framework; however, its scope was limited to pre-trained (zero-shot) models. To address these limitations, we propose Single-Cell Foundation Model Evaluation (scFME)--a systematic method designed to benchmark fine-tuned foundation models for insilico perturbation (ISP). scFME ensures comprehensive and robust assessment by requiring sufficient separation between control and perturbed cells at the outset and by quantifying ISP accuracy against zero and random perturbation baselines. Furthermore, scFME enables exploration of model performance across distinct gene categories, facilitating biological interpretation and functional relevance. Using this framework, we evaluated several commonly used models (and some of their variants) and demonstrated that the methodology effectively characterizes their performance in ISP studies. Our results position scFME as a versatile and rigorous methodology for evaluating and comparing current and future foundation models.

bioinformatics↗

Evaluating Foundation Models for In-Silico Perturbation

In-silico perturbation (ISP) offers a scalable alternative to traditional gene perturbation experiments, yet evaluation of foundation models for ISP remains underexplored. We introduce a novel evaluation framework, the single cell in-silico perturbation framework (scISP), to benchmark ISP models against in-vitro experimental data using biologically meaningful metrics, including cell state separation accuracy, ISP accuracy, and mean reciprocal rank (MRR) for predicting perturbed genes. Complementary functional analyses evaluate model performance across diverse gene categories. Using scISP, we assess two well-known pre-trained foundation models, Geneformer and scGPT, alongside the deep learning model, GEARS, highlighting their respective strengths and limitations in simulating cell state transitions and identifying perturbed genes. These analyses reveal intrinsic differences across models, offering opportunities to optimize foundation models for specific biological contexts or gene categories. Our extensible framework establishes a robust bridge between computational predictions and experimental validation, advancing gene perturbation research and biological discovery.

bioinformatics↗

Benchmarking tools for transcription factor prioritization

Spatiotemporal regulation of gene expression is controlled by transcription factor (TF) binding to regulatory elements, resulting in a plethora of cell types and cell states from the same genetic information. Due to the importance of regulatory elements, various sequencing methods have been developed to localise them in genomes, for example using ChIP-seq profiling of the histone mark H3K27ac that marks active regulatory regions. Moreover, multiple tools have been developed to predict TF binding to these regulatory elements based on DNA sequence. As altered gene expression is a hallmark of disease phenotypes, identifying TFs driving such gene expression programs is critical for the identification of novel drug targets. In this study, we curated 84 chromatin profiling experiments (H3K27ac ChIP-seq) where TFs were perturbed through e.g., genetic knockout or overexpression. We ran nine published tools to prioritize TFs using these real-world data sets and evaluated the performance of the methods in identifying the perturbed TFs. This allowed the nomination of three frontrunner tools, namely RcisTarget, MEIRLOP and monaLisa. Our analyses revealed opportunities and commonalities of tools that will help to guide further improvements and developments in the field.

bioinformatics↗

Integrative proteogenomics for differential expression and splicing variation in a DM1 mouse model

Dysregulated mRNA splicing is involved in the pathogenesis of many diseases including cancer, neurodegenerative diseases, and muscular dystrophies such as myotonic dystrophy type 1 (DM1). Comprehensive assessment of dysregulated splicing on the transcriptome and proteome level has been methodologically challenging, and thus investigations have often been targeting only few genes. Here, we performed a large-scale coordinated transcriptomic and proteomic analysis to characterize a DM1 mouse model (HSALR) in comparison to wild-type. Our integrative proteogenomics approach comprised gene- and splicing-level assessments for mRNAs and proteins. It recapitulated many known instances of aberrant mRNA splicing in DM1 and identified new ones. It enabled the design and targeting of splicing-specific peptides and confirmed the translation of known instances of aberrantly spliced disease-related genes (e.g. Atp2a1, Bin1, Ryr1), complemented by novel findings (e.g. Ywhae, Flnc, Svil). Comparative analysis of large-scale mRNA and protein expression data showed quantitative agreement of differentially expressed genes and splicing patterns between disease and wild-type. We hence propose this work as a suitable blueprint for a robust and scalable integrative proteogenomic strategy geared towards advancing our understanding of splicing-based disorders. With such a strategy, splicing-based biomarker candidates emerge as an attractive and accessible option, as they can be efficiently asserted on the mRNA and protein level in coordinated fashion. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=150 SRC="FIGDIR/small/443842v2_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@593246org.highwire.dtl.DTLVardef@1f3b5bforg.highwire.dtl.DTLVardef@12113b3org.highwire.dtl.DTLVardef@947d8f_HPS_FORMAT_FIGEXP M_FIG C_FIG

genomics↗

Gene-signatures predict biologically relevant dose-response potencies in phenotypic assays

Multiplexed gene-signature-based phenotypic assays are increasingly used for the identification and profiling of small molecule-tool compounds and drugs. Here we introduce a method (provided as R-package) for the quantification of the dose-response potency of a gene-signature as EC50 and IC50 values.\n\nTwo signaling pathways were used as models to validate our methods: beta-adrenergic agonistic activity on cAMP generation (dedicated dataset generated for this study) and EGFR inhibitory effect on cancer cell viability. In both cases, potencies derived from multi-gene expression data were highly correlated with orthogonal potencies derived from cAMP and cell growth readouts, and superior to potencies derived from single individual genes.\n\nOur results show that gene-signature potencies are a novel valid alternative to conventional readouts for compound potency quantification, in particular in scenarios where no other established readouts are available.

bioinformatics↗